{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:10:03Z","timestamp":1779307803875,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jaad.2013.09.014","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T07:08:32Z","timestamp":1381475312000},"page":"922-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: A prospective controlled study"],"prefix":"10.1016","volume":"69","author":[{"given":"Maria","family":"Dalamaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Basios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Vaggopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Kassanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eftihios","family":"Trakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.09.014_bib1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.09.014_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaad.2013.09.014_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1043-2760(96)00125-7","article-title":"New perspectives in polycystic ovary syndrome","volume":"7","author":"Diamanti-Kandarakis","year":"1996","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jaad.2013.09.014_bib4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3109\/09513590.2012.683058","article-title":"The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome","volume":"28","author":"Trakakis","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jaad.2013.09.014_bib5","first-page":"478","article-title":"Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance","volume":"36","author":"Vaggopoulos","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jaad.2013.09.014_bib6","first-page":"3110","article-title":"Selective insulin resistance in the polycystic ovary syndrome","volume":"84","author":"Book","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2013.09.014_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/ENDO:30:1:45","article-title":"Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS","volume":"30","author":"Teede","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.jaad.2013.09.014_bib8","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","article-title":"Defects in insulin receptor signaling in\u00a0vivo in the polycystic ovary syndrome (PCOS)","volume":"281","author":"Dunaif","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jaad.2013.09.014_bib9","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaad.2013.09.014_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5694\/j.1326-5377.2007.tb01273.x","article-title":"Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome","volume":"187","author":"Dabadghao","year":"2007","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaad.2013.09.014_bib11","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2013.09.014_bib12","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2337\/diabetes.53.9.2353","article-title":"Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome: phenotype and associated factors","volume":"53","author":"Gambineri","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jaad.2013.09.014_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jaad.2013.09.014_bib14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/humrep\/det002","article-title":"Assessment of impaired glucose tolerance prevalence with hemoglobin A1c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study","volume":"28","author":"Celik","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaad.2013.09.014_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.jaad.2013.09.014_bib16","first-page":"251","article-title":"The SAHA syndrome","volume":"54","author":"Orfanos","year":"2000","journal-title":"Horm Res"},{"key":"10.1016\/j.jaad.2013.09.014_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1468-3083.2010.03937.x","article-title":"Acne-associated syndromes: models for better understanding of acne pathogenesis","volume":"25","author":"Chen","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.09.014_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2013.09.014_bib19","first-page":"253","article-title":"The prevalence of phenotypic subgroups in Greek women with polycystic ovarian syndrome","volume":"40","author":"Vaggopoulos","year":"2013","journal-title":"Clin Exp Obstet Gyn"},{"key":"10.1016\/j.jaad.2013.09.014_bib20","first-page":"995","article-title":"The evaluation and management of hirsutism","volume":"101","author":"Azziz","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2013.09.014_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0378-6323.51258","article-title":"Scoring systems in acne vulgaris","volume":"75","author":"Adityan","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2013.09.014_bib22","doi-asserted-by":"crossref","unstructured":"Trakakis E, Papadavid E, Dalamaga M, Koumaki D, Stavrianeas N, Rigopoulos D, et al. Prevalence of non classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with acne: a hospital-based cross-sectional study. J Eur Acad Dermatol Venereol http:\/\/dx.doi.org\/10.1111\/j.1468-3083.2012.04613.x. Published online June 15, 2012.","DOI":"10.1111\/j.1468-3083.2012.04613.x"},{"key":"10.1016\/j.jaad.2013.09.014_bib23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaad.2013.09.014_bib24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaad.2013.09.014_bib25","series-title":"Influence of metformin and oral contraceptives in serum adiponectin and resistin levels in PCOS women","author":"Basios","year":"2012"},{"key":"10.1016\/j.jaad.2013.09.014_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/derm.1.2.8354","article-title":"Hormones and the pilosebaceous unit","volume":"1","author":"Chen","year":"2009","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.jaad.2013.09.014_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1529-8019.2006.00077.x","article-title":"Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome","volume":"19","author":"Lowenstein","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2013.09.014_bib28","first-page":"304","article-title":"SAHA syndrome: female androgenetic alopecia and hirsutism","volume":"8","author":"Camacho","year":"1999","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.09.014_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/humrep\/der418","article-title":"Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study","volume":"27","author":"Panidis","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaad.2013.09.014_bib30","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","article-title":"Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes","volume":"94","author":"Guastella","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2013.09.014_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.beem.2006.02.001","article-title":"Mild androgen phenotypes","volume":"20","author":"Carmina","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2013.09.014_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaad.2013.09.014_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0365-05962011000100015","article-title":"Polycystic ovary syndrome: a dermatologic approach","volume":"86","author":"Moura","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2013.09.014_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jaad.2013.09.014_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaad.2013.09.014_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.maturitas.2010.05.004","article-title":"Adipocyte factors, high-sensitive C-reactive protein levels and lipoxidative stress products in overweight postmenopausal women with normal and impaired OGTT","volume":"67","author":"Kassi","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.jaad.2013.09.014_bib37","doi-asserted-by":"crossref","first-page":"258S","DOI":"10.3945\/ajcn.2009.28449C","article-title":"Adiponectin in insulin resistance: lessons from translational research","volume":"91","author":"Ziemke","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jaad.2013.09.014_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental etiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jaad.2013.09.014_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/JOE-12-0577","article-title":"Prenatal androgen excess programs metabolic derangements in pubertal female rats","volume":"217","author":"Yan","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jaad.2013.09.014_bib40","doi-asserted-by":"crossref","first-page":"e11302","DOI":"10.1371\/journal.pone.0011302","article-title":"Androgen excess produces systemic oxidative stress and predisposes to beta-cell failure in female mice","volume":"5","author":"Liu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2013.09.014_bib41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.fertnstert.2008.06.021","article-title":"Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS","volume":"92","author":"Landay","year":"2009","journal-title":"Fertil Steril"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:27:51Z","timestamp":1759271271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213009651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0190962213009651"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.09.014","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: A prospective controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}